$2.86
0.05[1.78%]
At close: Apr 22
$2.86
0[0.00%]
PreMarket: 5:33PM EDT
Generation Bio
(NASDAQ:GBIO)Generation Bio Stock (NASDAQ:GBIO), Analyst Ratings, Price Targets, Predictions
Generation Bio Co has a consensus price target of $5.5, established from looking at the 25 latest analyst ratings. The last 3 analyst ratings were released from Needham, Wedbush, and Needham on April 10, 2024, March 7, 2024, and March 7, 2024. With an average price target of $8.33 between Needham, Wedbush, and Needham, there's an implied 191.38% upside for Generation Bio Co from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Wedbush
JMP Securities
TD Cowen
JP Morgan
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Generation Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | GBIO | Buy Now | Generation Bio | $2.86 | 249.65% | Needham | Gil Blum | → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2024 | GBIO | Buy Now | Generation Bio | $2.86 | 74.83% | Wedbush | David Nierengarten | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | GBIO | Buy Now | Generation Bio | $2.86 | 249.65% | Needham | Gil Blum | $14 → $10 | Maintains | Buy | Get Alert |
| 11/10/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 214.69% | Wedbush | David Nierengarten | $11 → $9 | Maintains | Outperform | Get Alert |
| 10/23/2023 | GBIO | Buy Now | Generation Bio | $2.86 | — | JMP Securities | Silvan Tuerkcan | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/19/2023 | GBIO | Buy Now | Generation Bio | $2.86 | — | TD Cowen | Yaron Werber | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/16/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 214.69% | JP Morgan | Anupam Rama | $8 → $9 | Maintains | Neutral | Get Alert |
| 08/03/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 389.51% | Needham | Gil Blum | → $14 | Reiterates | → Buy | Get Alert |
| 08/03/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 284.62% | Wedbush | David Nierengarten | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 389.51% | Needham | Gil Blum | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 389.51% | Needham | Gil Blum | → $14 | Reiterates | → Buy | Get Alert |
| 03/24/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 144.76% | JMP Securities | Silvan Tuerkcan | → $7 | Reiterates | → Market Outperform | Get Alert |
| 03/23/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 389.51% | Needham | Gil Blum | → $14 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | GBIO | Buy Now | Generation Bio | $2.86 | -22.03% | JMP Securities | Silvan Tuerkcan | $7 → $2.23 | Maintains | Market Outperform | Get Alert |
| 02/24/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 424.48% | Wedbush | David Nierengarten | $24 → $15 | Maintains | Outperform | Get Alert |
| 02/24/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 389.51% | Needham | Gil Blum | $23 → $14 | Maintains | Buy | Get Alert |
| 01/19/2023 | GBIO | Buy Now | Generation Bio | $2.86 | 144.76% | JMP Securities | Silvan Tuerkcan | $11 → $7 | Maintains | Market Outperform | Get Alert |
| 11/08/2022 | GBIO | Buy Now | Generation Bio | $2.86 | 214.69% | Canaccord Genuity | Whitney Ijem | → $9 | Initiates | → Buy | Get Alert |
| 08/08/2022 | GBIO | Buy Now | Generation Bio | $2.86 | 284.62% | JMP Securities | Silvan Tuerkcan | $10 → $11 | Maintains | Market Outperform | Get Alert |
FAQ
What is the target price for Generation Bio (GBIO)?
The latest price target for Generation Bio (NASDAQ: GBIO) was reported by Needham on April 10, 2024. The analyst firm set a price target for $10.00 expecting GBIO to rise to within 12 months (a possible 249.65% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Generation Bio (GBIO)?
The latest analyst rating for Generation Bio (NASDAQ: GBIO) was provided by Needham, and Generation Bio reiterated their buy rating.
When was the last upgrade for Generation Bio (GBIO)?
There is no last upgrade for Generation Bio.
When was the last downgrade for Generation Bio (GBIO)?
The last downgrade for Generation Bio Co happened on October 23, 2023 when JMP Securities changed their price target from N/A to N/A for Generation Bio Co.
When is the next analyst rating going to be posted or updated for Generation Bio (GBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Generation Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Generation Bio was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Generation Bio (GBIO) correct?
While ratings are subjective and will change, the latest Generation Bio (GBIO) rating was a reiterated with a price target of $0.00 to $10.00. The current price Generation Bio (GBIO) is trading at is $2.86, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.